Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
US OptionsDetailed Quotes
LGND250516C180000
- 1.70
- 0.000.00%
15min DelayClose May 1 16:00 ET
0.00High0.00Low
1.70Open1.70Pre Close0 Volume3 Open Interest180.00Strike Price0.00Turnover174.83%IV66.47%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier15DDays to Expiry1.70Extrinsic Value100Contract SizeAmericanOptions Type0.1064Delta0.0048Gamma64.21Leverage Ratio-0.2359Theta0.0040Rho6.83Eff Leverage0.0402Vega
Ligand Pharmaceuticals Newsroom
Craig-Hallum Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating
Ligand Pharmaceuticals Analyst Ratings
Stifel Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Maintains Target Price $143
Stifel Initiates Ligand Pharmaceuticals(LGND.US) With Buy Rating, Announces Target Price $143
Barclays Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Maintains Target Price $160
RBC Capital Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Maintains Target Price $155
Benchmark Co. Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Maintains Target Price $135
Oppenheimer Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Cuts Target Price to $142
A Quick Look at Today's Ratings for Ligand Pharmaceuticals(LGND.US), With a Forecast Between $135 to $160
RBC Raises Price Target on Ligand Pharmaceuticals to $155 From $143, Keeps Outperform Rating
Barclays Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Maintains Target Price $160
Craig-Hallum Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating
Craig-Hallum Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating
Benchmark Co. Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Maintains Target Price $135
Ligand Pharmaceuticals Is Maintained at Overweight by Barclays
Barclays Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Maintains Target Price $160
Ligand Pharmaceuticals Is Maintained at Outperform by RBC Capital
Craig-Hallum Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating
Oppenheimer Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Raises Target Price to $151
RBC Capital Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Raises Target Price to $143
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now